Old Web
English
Sign In
Acemap
>
authorDetail
>
Adam Waxman
Adam Waxman
University of Pennsylvania
Medicine
Internal medicine
Multiple myeloma
Oncology
Proteasome inhibitor
7
Papers
73
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
B‐cell maturation antigen chimeric antigen receptor T‐cell re‐expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor‐based combination therapy
2021
British Journal of Haematology
Luca Bernabei
Lifeng Tian
Alfred L. Garfall
J. Joseph Melenhorst
Simon F. Lacey
Edward A. Stadtmauer
Dan T. Vogl
Vanessa E. Gonzalez
Gabriela Plesa
Regina M. Young
Adam Waxman
Bruce L. Levine
Carl H. June
Michael C. Milone
Adam D. Cohen
Show All
Source
Cite
Save
Citations (0)
Overall Survival Remains Important in Trials of Early-Line Multiple Myeloma Therapy
2021
Journal of Clinical Oncology
Alfred L. Garfall
Adam B. Cohen
Edward A. Stadtmauer
Sandra Susanibar-Adaniya
Dan T. Vogl
Adam Waxman
Show All
Source
Cite
Save
Citations (0)
Myeloma of the Base of Skull: Palliative Radiotherapy for Cranial Neuropathies
2020
International Journal of Radiation Oncology Biology Physics
Graeme R. Williams
Shwetha Manjunath
Anish A. Butala
Adam Waxman
Joshua Jones
John P. Plastaras
Ima Paydar
Show All
Source
Cite
Save
Citations (0)
Infectious Complications Following Venetoclax-Proteasome Inhibitor Based Regimens in Relapsed Myeloma: A Single Center Retrospective Analysis
2019
Blood
Christopher Tor Sauter
Luca Bernabei
Adam Waxman
Adam D. Cohen
Alfred L. Garfall
Dan T. Vogl
Sara Whittington
Colleen Erb
Patricia A. Mangan
Mary Sanchez
Edward A. Stadtmauer
Show All
Source
Cite
Save
Citations (0)
1